Efficacy of Switching From Teriparatide to Bisphosphonate or Denosumab: A Prospective, Randomized, Open‐Label Trial

There is no consensus on an optimal treatment after daily teriparatide (TPTD). We performed a prospective, randomized, open‐label, 12‐month trial to investigate the efficacy of follow‐up treatment after daily TPTD treatment for Japanese patients. Three‐hundred patients were enrolled in this study. P...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JBMR Plus
Hlavní autoři: Niimi, Rui, Kono, Toshibumi, Nishihara, Atsushi, Hasegawa, Masahiro, Kono, Toshihiko, Sudo, Akihiro
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6139701/
https://ncbi.nlm.nih.gov/pubmed/30283910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10054
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky